Adaptation of the Tool to Estimate Patient Costs Questionnaire into Indonesian Context for Tuberculosis-affected Households

Ahmad Fuady, Tanja A Houweling, Muchtaruddin Mansyur, Jan H Richardus

Abstract


Background: Indonesia is the second-highest country for tuberculosis (TB) incidence worldwide. Hence, it urgently requires improvements and innovations beyond the strategies that are currently being implemented throughout the country. One fundamental step in monitoring its progress is by preparing a validated tool to measure total patient costs and catastrophic total costs. The World Health Organization (WHO) recommends using a version of the generic questionnaire that has been adapted to the local cultural context in order to interpret findings correctly. This study is aimed to adapt the Tool to Estimate Patient Costs questionnaire into the Indonesian context, which measures total costs and catastrophic total costs for tuberculosis-affected households. Methods: the tool was adapted using best-practice guidelines. On the basis of a pre-test performed in a previous study (referred to as Phase 1 Study), we refined the adaptation process by comparing it with the generic tool introduced by the WHO. We also held an expert committee review and performed pre-testing by interviewing 30 TB patients. After pre-testing, the tool was provided with complete explanation sheets for finalization. Results: seventy-two major changes were made during the adaptation process including changing the answer choices to match the Indonesian context, refining the flow of questions, deleting questions, changing some words and restoring original questions that had been changed in Phase 1 Study. Participants indicated that most questions were clear and easy to understand. To address recall difficulties by the participants, we made some adaptations to obtain data that might be missing, such as tracking data to medical records, developing a proxy of costs and guiding interviewers to ask for a specific value when participants were uncertain about the estimated market value of property they had sold. Conclusion: the adapted Tool to Estimate Patient Costs in Bahasa Indonesia is comprehensive and ready for use in future studies on TB-related catastrophic costs and is suitable for monitoring progress to achieve the target of the End TB Strategy.

Keywords


tuberculosis; patient costs; catastrophic costs; adaptation; Indonesia

References


WHO. Global tuberculosis report. Geneva: World Health Organization; 2016.

Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43(6):1763-75.

K.F. O, Salomon JA, Barnighausen T, Atun R. Stopping tuberculosis: a biosocial model for sustainable development. Lancet. 2015;386:2354-62.

Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining Catastrophic Costs and Comparing Their Importance for Adverse Tuberculosis Outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru. Plos Medicine. 2014;11(7).

Organization WH. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization, 2013 29 November 2013. Report No.: EB134/12.

Organization WH. Protocol for survey to determine direct and indirect costs due to TB and to estimate proportion of TB-affected households experiencing catastrophic total costs due to TB. Geneva: World Health Organization; 2015 November 2015.

Mauch V, Woods N, Kirubi B, Kipruto H, Sitienei J, Klinkenberg E. Assessing access barriers to tuberculosis care with the tool to Estimate Patients' Costs: pilot results from two districts in Kenya. Bmc Public Health. 2011;11.

TB-CTA. The tool to estimate patient's costs. The Hague: KNCV; 2009 2009.

Epstein J, Santo RM, Guillemin F. A review of guidelines for cross-cultural adaptation of questionnaires could not bring out a consensus. J Clin Epidemiol. 2015;68(4):435-41.

Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res2010.

Tiemersma E, Hafidz F. Costs faced by (multidrug resistant) tuberculosis patients during diagnosis and treatment: report from a pilot study in Indonesia. The Hague: KNCV Tuberculosis Foundation, 2014 February 2014. Report No.

van den Hof S, Collins D, Hafidz F, Beyene D, Tursynbayeva A, Tiemersma E. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan. BMC Infect Dis. 2016;16:470.

Bruyere O, Demoulin M, Beaudart C, Hill JC, Maquet D, Genevay S, et al. Validity and Reliability of the French Version of the STarT Back Screening Tool for Patients With Low Back Pain. Spine. 2014;39(2):E123-E8.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186-91.


Full Text: PDF ANEX-1 ANEX-2 ANEX-3

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Acta Medica Indonesiana